This webinar is part of Bioprocess Webinar Series. See other webinars in this series on our webinar page - Advanced Trends and Tools for Gene Therapy and Advanced Trends and Tools for Stem Cell Therapy.
With key advancements in cancer immunotherapies, the need for autologous T-cell manufacturing technologies that cost-effectively scale from pre-clinical to commercial production is becoming critical. Leveraging our long and expert history in cell culture, Corning is driving the development of clinical cell expansion platforms designed to reduce manufacturing time and drive down production costs. This webinar will introduce you to the new tools and solutions that Corning has developed for the field of immune cell therapy, as well as applications related to CAR-T therapies.
After graduating from Biochemistry from the University of Santiago (Chile), Constanza perused a career in the Chilean animal health industry, developing as a Bioprocess Scientist for vaccine production in charge of scale-up and tech transfer. She furthered developed her career in Belgium, in the field of antibody production in suspension cell lines. Constanza is currently a Field Application Scientist for the EMEA region, providing customers in-depth technical support, presenting seminars and trainings, and assisting customers in experimental set-up and troubleshooting.